ALLEGRA, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 4.983
NA - Nord America 3.717
AS - Asia 3.317
SA - Sud America 300
AF - Africa 111
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.453
Nazione #
US - Stati Uniti d'America 3.567
GB - Regno Unito 1.711
CN - Cina 1.049
SG - Singapore 1.013
DE - Germania 770
IT - Italia 695
RU - Federazione Russa 427
SE - Svezia 371
VN - Vietnam 283
UA - Ucraina 270
HK - Hong Kong 231
IN - India 206
BR - Brasile 190
NL - Olanda 163
FR - Francia 155
KR - Corea 148
TR - Turchia 144
IE - Irlanda 127
CA - Canada 119
FI - Finlandia 108
EU - Europa 92
CO - Colombia 63
CI - Costa d'Avorio 51
ID - Indonesia 48
GR - Grecia 45
BD - Bangladesh 43
JP - Giappone 36
BE - Belgio 24
AU - Australia 23
IQ - Iraq 22
NO - Norvegia 20
PL - Polonia 18
RO - Romania 17
AR - Argentina 16
EG - Egitto 15
PK - Pakistan 14
MX - Messico 13
ZA - Sudafrica 13
AL - Albania 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
MA - Marocco 9
PE - Perù 8
VE - Venezuela 8
DK - Danimarca 7
IR - Iran 7
TH - Thailandia 7
ES - Italia 6
MY - Malesia 6
SA - Arabia Saudita 6
PH - Filippine 5
PT - Portogallo 5
CL - Cile 4
CZ - Repubblica Ceca 4
EC - Ecuador 4
KE - Kenya 4
LB - Libano 4
LK - Sri Lanka 4
TW - Taiwan 4
UY - Uruguay 4
UZ - Uzbekistan 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
LT - Lituania 3
LU - Lussemburgo 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BB - Barbados 2
CD - Congo 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
MK - Macedonia 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
JM - Giamaica 1
JO - Giordania 1
Totale 12.531
Città #
Southend 1.514
Singapore 564
Ashburn 352
Chandler 312
Hanover 269
Beijing 255
Jacksonville 248
San Jose 238
Hong Kong 215
Milan 213
Seattle 201
Princeton 166
Wilmington 127
Dublin 124
Santa Clara 121
Council Bluffs 116
Ann Arbor 108
Redmond 99
Bengaluru 97
Mountain View 90
Nanjing 89
Ho Chi Minh City 88
Toronto 88
Los Angeles 87
Dallas 78
Saint Petersburg 74
Hanoi 73
Munich 70
Serra 69
Sakarya 65
Hefei 63
Lauterbourg 63
Andover 60
Bogotá 59
Fairfield 59
Pisa 59
Shanghai 56
Des Moines 53
Moscow 52
Abidjan 51
Woodbridge 51
Somerville 48
Houston 47
Boardman 42
Buffalo 41
Athens 40
Dearborn 39
New York 36
Guangzhou 35
Rome 34
Phoenix 32
Cangzhou 30
Tianjin 27
Tokyo 26
Helsinki 25
Frankfurt am Main 24
Jinan 24
Nanchang 24
Shenyang 24
São Paulo 23
The Dalles 23
Brussels 21
Hangzhou 21
Columbus 19
Eitensheim 19
Da Nang 18
Auburn Hills 16
Nuremberg 16
Berlin 15
Orem 15
Cambridge 14
Fuzhou 14
Turku 14
Seoul 13
Verona 13
Warsaw 13
Ottawa 12
Changsha 11
Lanzhou 11
Medford 11
Quanzhou 11
Washington 11
Baghdad 10
Jakarta 10
Mumbai 10
San Diego 10
Bitonto 9
Kiez 9
London 9
Shenzhen 9
Bologna 8
Chandigarh 8
Chennai 8
Dong Ket 8
Hebei 8
Lima 8
Medan 8
Redwood City 8
Tirana 8
Bandung 7
Totale 7.943
Nome #
Beta-thalassemia and pulmonary function 405
Malattie respiratorie : l'essenziale 308
How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan 304
Increased frequency dependence of specific airway resistance in patients with laryngeal hemiplegia 274
Aerosolized hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma 267
Increased keratin content detected by proteomic analysis of exhaled breath condensate from healthy persons who smoke 262
Chlamydia pneumoniae and Mycoplasma pneumoniae 255
Anxiety and depression in COPD patients : the roles of gender and disease severity 243
Azithromycin and lower respiratory tract infections 236
Clearance mucociliare per immagini 227
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 226
Aerosol of hyaluronan partially prevent bronchocostriction induced by ultrasonically nebulised water in asthmatics 225
Chlamydia pneumoniae and chronic bronchitis : association with severity and bacterial clearance following treatment 220
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease 219
Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice 216
High altitude exposure reduce bronchial responsiveness to hypo-osmolar aerosol in lowland asthmatics 211
Effects of salmeterol on cilia and mucus in COPD and Pneumonia patients 208
Tobramycin by aerosol (Toby ® )eradicates Pseudomonas aeruginosa resistant to Tobramycin i.v. in patients with infected bronchiectasis 208
Protective effect of hyaluronic acid on the effects of bronchoprovocation with methacholine challenge in asthmatics 205
In vitro antibiotic activity against Chlamydia pneumoniae clinical isolates 199
TNF-alpha in exhaled breath condensate and in serum of scleroderma patients 198
Comparison of bronchodilator effects induced by salbutamol between traditional spirometry and a new ultrasound pneumography 198
Usefulness of Specific Airway Resistance in Preschool Children with Cystic Fibrosis 198
Effect of supine posture on respiratory values in patients with cystic fibrosis 197
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 197
Bronchoprotective activity of Sildenafil (Viagra) in asthmatics 194
Increase of TNF-α levels in breath condensate and in serum of COPD subjects 192
Increased of TNF-alfa levels in breath condensate and in serum of COPD subjects 190
High Molecular weight preparation of hyaluronic acid protect asthmatics from challenge-induced bronchocostriction, while a low molecular weight preparation does not 188
Comment on Emissions from brake linings and tires : case studies of Stockholm, Sweden 1995/1998 and 2005 186
Effect on the body supine position on diffusion capacity in sclerodermic patients 185
Nonspecific bronchial responsiveness at high altitude in nonresident asthmatic subjects. 184
Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients 182
Lung function in beta-thalassemia patients : a longitudinal study 181
Evaluating Health-Related Quality of Life, Work Ability, and Disability in Pulmonary Arterial Hypertension An Unmet Need 180
Variation of FEV1 Versus Reactant and Resonant Frequency for Forced Oscillation Technique During Metacholine Challenge in Asthmatics 176
Role of macrolides as immunomodular agents 175
La terapia della tubercolosi 175
The possible impact of "sequential co-exposure" on ozone associated adverse health effects. Preliminary data from cumulative cross sectional and prospective studies in Milan 173
Organizzazione del 6 Congresso Pneumologico Ambrosiano 172
Respiratory evaluation in Down's syndrome 169
Comorbidity, Hospitalization, and Mortality in COPD : Results from a Longitudinal Study 168
Chlamydia pneumoniae : crossing the barriers? 167
Colonisation in Stable Patients with COPD: Results of an Italian Epidemiological Study (Prime Study) 165
Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollution. 161
Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthma 157
Nacetylcystein reduces 8 Isoprostane Levels in Exhaled Breath Condensate and Serum of COPD Patients 155
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. 155
Exhaled breath condensade (EBC) helps the detection of oxidative stress in Beta thalassemia major 154
Increased 8-isoprostane in the exhaled breath condensate of Down patients 152
Comparison of variation of FEV1 and forced oscillation technique during methacholine challenge 151
Echocardiography in pulmonary arterial hypertension : an essential tool 148
Pulmonary arterial hypertension : the key role of echocardiography 146
Forced oscillation technique in patients with scleroderma, idiopathic pulmonary fibrosis (IPF) and connective diseases 145
Principali quadri clinici della tuberolosi e loro storia naturale 145
Non-phospholipid vesicles for pulmonary glucocorticoid delivery 142
Affect of supine posture on respiratory values in healthy ad COPD subjects 142
Non-CF bronchietasis, an obstructive disease. Similarities with COPD? 140
Increased 8-isoprostane in breath condensate and serum of Down patients 132
Mucoactive drugs 129
Standards of care and clinical predictors in patients hospitalised for a copd exacerbation the italian SOS (stratification observation study) 127
Increased 8-isoprostane in breath condensate in beta-thalassemia patients 120
TBC e BPCO 118
Upregulation of CD23 (FceRII) Expression in human Airways Smooth Muscle Cells After Exposure to IL13 117
Histamine levels following adenosine monophosphate challenge 108
Antitussive activity and respiratory system effects of levodropropizine in man 107
Corso di formazione ECM teorico-pratico in patologia respiratoria 105
Extravascular lung fluid accumulation does not immediately follow the increase capillary permeability during exposure to high altitude (HA) 105
Nasal ciliary function and ultrastructure in Down syndrome 103
Effect of atropine on ciliary beat in human upper respiratory tract epithelial cells 97
Efficacia e tollerabilita del ceftibuten nel trattamento delle esacerbazioni batteriche della bronchite cronica in una popolazione anziana 93
Observations on respirable allergens (pollens and mites) in a resort located in Sharm-el-Sheikh, Egypt 91
The oxydoreductive phenomena and the respiratory apparatus 70
Influenza in patients with chronic respiratory diseases. A comparison between two prophylactic regimens in elderly patients 64
Totale 13.087
Categoria #
all - tutte 31.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021366 0 0 0 0 0 0 0 0 0 0 312 54
2021/20221.122 113 62 34 49 31 36 222 136 128 77 80 154
2022/20231.079 152 90 103 103 134 225 20 61 141 16 25 9
2023/2024540 17 50 37 16 109 54 12 35 19 38 63 90
2024/20251.574 81 109 33 215 147 26 50 169 83 119 128 414
2025/20262.981 407 174 312 278 324 235 420 161 296 231 143 0
Totale 13.087